AXIM Biotechnologies's market cap is currently $1.03M. The company's EPS TTM is $-0.018; its P/E ratio is ―; AXIM Biotechnologies is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 39.52K	$ 8.88K	$ 60.46K	$ 0.00	$ 799.48K
Gross Profit	$ 39.52K	$ -417.25K	$ 60.46K	$ -16.00K	$ 223.79K
Operating Income	$ -2.75M	$ -4.65M	$ -7.99M	$ -4.95M	$ -6.51M
EBITDA	$ -6.43M	$ -3.94M	$ -13.17M	$ -4.93M	$ -6.51M
Net Income	$ -8.06M	$ -5.96M	$ -16.52M	$ -6.73M	$ -6.77M
Balance Sheet
Cash & Short-Term Investments	$ 156.46K	$ 47.28K	$ 452.96K	$ 457.18K	$ 752.87K
Total Assets	$ 4.12M	$ 4.21M	$ 5.32M	$ 11.31M	$ 1.69M
Total Debt	$ 5.89M	$ 5.66M	$ 6.72M	$ 6.31M	$ 6.10M
Net Debt	$ 5.74M	$ 5.62M	$ 6.27M	$ 5.85M	$ 5.59M
Total Liabilities	$ 11.78M	$ 9.04M	$ 7.66M	$ 9.75M	$ 8.45M
Stockholders' Equity	$ -7.66M	$ -4.83M	$ -2.34M	$ 1.57M	$ -6.76M
Cash Flow
Free Cash Flow	$ -1.03M	$ -2.05M	$ -2.54M	$ -3.31M	$ -5.02M
Operating Cash Flow	$ -1.03M	$ -2.04M	$ -2.49M	$ -3.22M	$ -5.02M
Investing Cash Flow	$ 0.00	$ -8.71K	$ -50.49K	$ 9.98K	$ 348.19K
Financing Cash Flow	$ 1.14M	$ 1.65M	$ 2.53M	$ 3.15M	$ 3.38M

Currency in USD

AXIM Biotechnologies Earnings and Revenue History

Income Statement >

AXIM Biotechnologies Debt to Assets

Balance Sheet >

AXIM Biotechnologies Cash Flow

Cash Flow >

AXIM Biotechnologies Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing